The Effectiveness and Safety of Dong-A Opalmon® Tablet in Patients With Acquired Lumbar Spinal Stenosis

NCT06654856 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 107

Last updated 2026-02-27

No results posted yet for this study

Summary

This study is to evaluate the Effectiveness and Safety of Dong-A Opalmon® Tablet in Patients With Acquired Lumbar Spinal Stenosis

Conditions

  • Lumbar Spinal Stenosis

Sponsors & Collaborators

  • Dong-A ST Co., Ltd.

    lead INDUSTRY

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-16
Primary Completion
2026-02-23
Completion
2026-02-23

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06654856 on ClinicalTrials.gov